Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276456 · ClinicalTrials.gov registry record · NA
The Impact of Early Follow-up on Readmission Rates in AMI Patients
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 221
- Enrollment target
NCT02276456 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 221 participants.
The verdict
NCT02276456, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 221 participants
- Enrollment target
Study Summary
With no prior prospective study to demonstrate the benefit of an early post-discharge follow-up appointment in reducing readmission rates in the post-myocardial infarction (MI patient population, we propose to conduct the first randomized, prospective trial to better elucidate the association between early and standard follow-up on readmission rates. The investigators hypothesize that unlike heart failure or advanced valvular disease patients, the benefit of early outpatient follow-up in reducing readmission of post-MI patients will be less clear. Thus, the investigators primary aim will be to determine the effect of early outpatient follow-up post-discharge on 90 day all-cause readmission rates (exclusive of planned readmissions known at the time of discharge). Secondary aims are to describe 1) causes of readmissions within 90 days, 2) any cardiovascular-related complications and any deaths that occur from discharge through 90 days, 3) 30-day readmission rates and 4) median time to readmission among those readmitted. Finally, the investigators will examine the distribution of demographic, clinical and socioeconomic characteristic according to readmission vs. no readmission. The investigators do not expect to have sufficient endpoints for full predictive modeling, but believe this exploratory work will provide a foundation for future studies. The investigators postulate that the design and methodology of our current study could be used to answer similar questions in other subsets of patients.
Interventions
- BEHAVIORAL Follow-up Appointment- early vs standard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2014-03 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02276456
The ClinicalTrials.gov registry entry for NCT02276456 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Follow-up Appointment- early vs standard is the first listed.
NCT02276456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02276456 about?
NCT02276456 is a clinical study titled "The Impact of Early Follow-up on Readmission Rates in AMI Patients". With no prior prospective study to demonstrate the benefit of an early post-discharge follow-up appointment in reducing readmission rates in the post-myocardial infarction (MI patient population, we propose to conduct the first randomized, prospective trial to better elucidate the association betwee...
What is the current status of trial NCT02276456?
This trial is currently terminated. It is a NA study. The enrollment target is 221 participants. The study started on 2014-03. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02276456?
The interventions under investigation include: Follow-up Appointment- early vs standard (BEHAVIORAL).
Who is sponsoring clinical trial NCT02276456?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.